The risk of tachyarrhythmias in patients with moderate-to-severe chronic kidney disease receiving tiotropium bromide

被引：4
|
作者：
Mathioudakis, Alexander G. [1 ,2 ,3 ]
Mastoris, Ioannis [3 ,4 ]
Chatzimavridou-Grigoriadou, Victoria [2 ,3 ]
Mathioudakis, Georgios A. [2 ]
机构：
[1] Aintree Univ Hosp NHS Fdn Trust, Chest Ctr, Liverpool L9 7AL, Merseyside, England
[2] Athens Breath Ctr, Athens, Greece
[3] Hellen Soc Adv Biomed Res, Resp Assembly, Athens, Greece
[4] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 197卷
关键词：
Tiotropium; Arrhythmia; Mortality; COPD; Therapeutics; Human; COPD; HANDIHALER; MORTALITY; RESPIMAT; INHALER;
D O I：
10.1016/j.ijcard.2015.06.051
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [1] Moderate-to-severe psoriasis is associated with an increased risk of chronic kidney disease
    Purslow, Caroline
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (12) : 1160 - 1160
  • [2] Efficiency of Platelet Transfusion in Patients with Moderate-to-Severe Chronic Kidney Disease and Thrombocytopenia
    Ali, Sevigean
    Botnarciuc, Mihaela
    Daba, Lavinia Carmen
    Ispas, Sorina
    Stanigut, Alina Mihaela
    Pana, Camelia
    Burcila, Marian-Catalin
    Tuta, Liliana-Ana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (21)
  • [3] Efficacy And Safety Of Aclidinium Bromide Compared With Tiotropium And Placebo In Patients With Moderate-To-Severe COPD: A Phase Iiib Study
    Beier, J.
    Kirsten, A.
    Mroz, R.
    Segarra, R.
    Chuecos, F.
    Caracta, C.
    Gil, E. Garcia
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [4] Tiotropium plus formoterol versus tiotropium alone for stable moderate-to-severe chronic obstructive pulmonary disease: Ameta-analysis
    Zou, Yong
    Xiao, Jian
    Lu, Xiao Xiao
    Xia, Zi An
    Xie, Bin
    Li, Jun
    Chen, Qiong
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (01): : 269 - 278
  • [5] Kidney disease in moderate-to-severe psoriasis: commentary
    Wakkee, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (02) : 271 - 272
  • [6] Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis
    Rastogi, Anjay
    Fishbane, Steven
    Lerma, Edgar
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (05) : 387 - 400
  • [7] Predicting Factors for Rapid Progressive Chronic Kidney Disease in Primary Glomerular Disease Patients with Moderate-to-Severe Stage
    Tan, Jun
    Zhang, Hao
    Zheng, Wei
    Yang, Shikun
    Yang, Minghui
    Liu, Yan
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [8] IMPACT OF EDUCATIONAL ATTAINMENT ON HEALTH OUTCOMES IN MODERATE-TO-SEVERE CHRONIC KIDNEY DISEASE
    Morton, Rachael L.
    Schlackow, Iryna
    Staplin, Natalie
    Gray, Alastair
    Cass, Alan
    Haynes, Richard
    Emberson, Jonathan
    Herrington, Will
    Landray, Martin
    Baigent, Colin
    Mihaylova, Borislava
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [9] Cost Comparison of Urate-Lowering Therapies in Patients with Gout and Moderate-to-Severe Chronic Kidney Disease
    Mitri, Ghaith
    Wittbrodt, Eric T.
    Turpin, Robin S.
    Tidwell, Beni A.
    Schulman, Kathy L.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2016, 22 (04): : 326 - 336
  • [10] Dulaglutide Improves Kidney Fibrosis Biomarker Levels in Patients with Type 2 Diabetes and Moderate-to-Severe Chronic Kidney Disease
    Tuttle, Katherine R.
    Wilson, Jonathan M.
    Lin, Yanzhu
    Qian, Hui-Rong
    Kelly-Boruff, Kathleen
    Genovese, Federica
    Karsdal, Morten A.
    Duffin, Kevin L.
    Botros, Fady T.
    DIABETES, 2020, 69
12345